Medical Research & Talent|April 28, 2021
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Medical Research & Talent|November 20, 2020
At Whitehead Institute, Tobi Oni will focus on uncovering mechanisms for the poor anti-tumor immune response to pancreatic cancer, and work to develop novel ways of promoting tumor clearance by immune cells. And—following in his mother’s footsteps—he will pursue opportunities to inspire and mentor the next generation of scientists from diverse backgrounds.
Medical Research & Talent|March 28, 2017
The drug, ocrelizumab, is one of three new "B-cell" therapies to treat MS that have proven to be extremely effective in preventing MS relapses.